Filing Details
- Accession Number:
- 0001562180-25-001842
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-03 16:31:27
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-03
- Accepted Time:
- 2025-03-03 16:31:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1108501 | Ray Kurzweil | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-28 | 15,000 | $175.43 | 27,080 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-28 | 2,259 | $314.25 | 24,821 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 4,821 | $315.26 | 20,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 2,256 | $316.07 | 17,744 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 897 | $317.33 | 16,847 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 1,303 | $318.28 | 15,544 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 1,519 | $320.43 | 14,025 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 1,095 | $321.53 | 12,930 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 750 | $322.43 | 12,180 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-28 | 100 | $323.53 | 12,080 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2025-02-28 | 15,000 | $0.00 | 15,000 | $175.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-06-26 | 2025-06-26 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $313.71 USD to $314.69 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $314.71 USD to $315.70 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $315.71 USD to $316.575 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $316.81 USD to $317.78 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $317.84 USD to $318.705 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $320.02 USD to $321.015 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $321.02 USD to $322.00 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $322.03 USD to $322.85 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $323.46 USD to $323.58 USD. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
